Codexis (CDXS) Change in Account Payables (2010 - 2026)
Codexis' (CDXS) quarterly Change in Account Payables came in at $312000.0 in Q1 2026, down 84.89% year-on-year from $2.1 million in Q1 2025, and up 139.34% quarter-over-quarter from -$793000.0 in Q4 2025.
Codexis (CDXS) Change in Account Payables (2010 - 2026) Analysis & Trends
Codexis' Change in Account Payables history runs 17 years deep, the most recent figure standing at $312000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 84.89% year-over-year to $312000.0 in Q1 2026; TTM through Mar 2026 was -$3.0 million, a 297.85% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, up 49.9% from the prior year.
- Change in Account Payables advanced to $312000.0 in Q1 2026 per CDXS's latest filing, from -$793000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.4 million in Q4 2023 and bottomed at -$3.5 million in Q2 2025.
- The 5-year median for Change in Account Payables is $71000.0 (2022), against an average of -$61588.2.
- Across the five-year window, Change in Account Payables jumped 336.69% in 2022 and plunged 1361.18% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $558000.0 in 2022, then soared by 328.67% to $2.4 million in 2023, then slumped by 151.34% to -$1.2 million in 2024, then jumped by 35.42% to -$793000.0 in 2025, then soared by 139.34% to $312000.0 in 2026.
- Per Business Quant, the three latest CDXS Change in Account Payables figures stand at $312000.0 (Q1 2026), -$793000.0 (Q4 2025), and $905000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | -793,000.00 |
| Dec 31, 2025 | -793,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | -3.46 Mn |
| Jun 30, 2025 | -3.46 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Sep 30, 2024 | 936,000.00 |
| Sep 30, 2024 | 936,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Mar 31, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Dec 31, 2023 | 2.39 Mn |
| Dec 31, 2023 | 2.39 Mn |